Rivastigmine Tartrate (Carilion Materials Management)
Welcome to the PulseAid listing for the Rivastigmine Tartrate drug offered from Carilion Materials Management. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | Rivastigmine Tartrate |
SUBSTANCE NAME: | RIVASTIGMINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-07-01 |
END MARKETING DATE: | 0000-00-00 |
Rivastigmine Tartrate HUMAN PRESCRIPTION DRUG Details:
Item Description | Rivastigmine Tartrate from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.5(mg/1) |
START MARKETING DATE: | 2010-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-4134_3fc6b4c1-eb67-4c34-8feb-d1563e689592 |
PRODUCT NDC: | 68151-4134 |
APPLICATION NUMBER: | ANDA077131 |
Other RIVASTIGMINE TARTRATE Pharmaceutical Manufacturers / Labelers: